02:51 AM EST, 03/06/2025 (MT Newswires) -- Badreddin Edris, Chief Operating Officer, on March 03, 2025, sold 20,000 shares in SpringWorks Therapeutics ( SWTX ) for $1,084,592. Following the Form 4 filing with the SEC, Edris has control over a total of 169,712 common shares of the company, with 169,712 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1773427/000110465925021008/xslF345X05/tm258294-2_4seq1.xml